Public Health – Page 14

Persistent Medical Debt After Cancer Diagnosis: Insights from a Large Massachusetts Cohort Study

By MedXY 08/30/2025

A Massachusetts cohort study reveals modest but persistent increases in medical debt after cancer diagnosis, particularly in colorectal and bladder cancers, despite high insurance coverage. Total debt, bankruptcy rates, and credit scores remained largely unchanged in the overall population.

Cardiology Public Health Specialties

High-Dose Influenza Vaccines Cut Hospitalizations: Landmark Trials Shape Cardiovascular Prevention

By MedXY 08/30/2025

Two massive randomized trials show high-dose flu vaccines reduce influenza-related and cardiorespiratory hospitalizations in older adults, reinforcing vaccination as a vital cardiovascular prevention strategy.

Family Medicine & Nutrition Gastroenterology Psychiatry Public Health Specialties

Unraveling Chronic Stress: The Role of Gut Dysbiosis and Vitamin B6 Metabolism in Stress-Related Brain Disorders Independent of Cortisol

By MedXY 08/30/2025

Recent evidence reveals gut dysbiosis-induced vitamin B6 metabolic disturbances as a novel, cortisol-independent mechanism driving chronic stress-related abnormal behaviors and inflammation, highlighting probiotic and vitamin B6 supplementation as potential therapeutic strategies.

Emergency Medicine Infectious Diseases news Pediatrics Public Health Specialties

Enhancing Early Risk Stratification of Severe Childhood Febrile Illness in Rural Asia Using sTREM1 Biomarker

By MedXY 08/30/2025

A multicountry study across Asia demonstrates soluble TREM1's superior accuracy over traditional clinical signs in predicting severe febrile illness in children, potentially transforming triage in resource-limited settings.

Cardiology Public Health Respiratory Specialties

Ventilation Hoods During Cooking Significantly Reduce PM2.5 Exposure and Improve Cardiometabolic and Pulmonary Health: Evidence from a Cluster-Randomized Trial in Rural China

By MedXY 08/30/2025

A community-based intervention using ventilation hoods during cooking reduced 24-hour PM2.5 exposure by nearly 30% and improved cardiometabolic and pulmonary health markers in rural Chinese villages reliant on wood fuel.

Pediatrics Public Health Specialties

Promising Immunogenicity and Safety of the Live-Attenuated Intranasal RSV Vaccine in Infants and Toddlers

By MedXY 08/28/2025

This phase I/II trial demonstrates that the live-attenuated intranasal RSV vaccine (RSVt) is immunogenic and well-tolerated in infants and toddlers, offering a potential new preventive option against RSV infection.

Public Health Specialties

Evaluating Community-Wide Mass Drug Administration to Interrupt Soil-Transmitted Helminth Transmission: Insights from the DeWorm3 Trial

By MedXY 08/27/2025

The DeWorm3 trial assessed whether high-coverage community-wide mass drug administration with albendazole could interrupt soil-transmitted helminth transmission in Benin, India, and Malawi but found limited success, suggesting tailored approaches are needed.

Family Medicine & Nutrition news Public Health Specialties

The Slowing Pace of Longevity: Why Today’s Generations May Not Reach 100 Years

By MedXY 08/27/2025

Recent research reveals a significant slowdown in life expectancy growth, suggesting that contemporary generations may not achieve the rapid longevity gains of the past or routinely reach 100 years.

Cardiology Clinical Updates news Public Health Respiratory Specialties

Impact of E-cigarette Use on Cardiovascular Risk, Lung Function, and Clinical Outcomes in Smokers: Insights from a Randomised Placebo-Controlled Trial

By MedXY 08/25/2025

This review synthesizes trial evidence showing that nicotine-containing e-cigarettes modestly improve lipid profiles but cause no significant changes in lung function or other cardiovascular markers compared to cigarette substitutes in smokers reducing cigarette use.

Clinical Updates news Public Health Respiratory Specialties

Cytisinicline’s Promise in Smoking Cessation: Insights from the ORCA Phase 3 Replication Trial

By MedXY 08/25/2025

The ORCA-3 trial confirms cytisinicline's efficacy and safety for smoking cessation at 6 and 12 weeks, showing sustained abstinence and reduced nicotine craving up to 24 weeks.

Clinical Updates Pediatrics Public Health Specialties

Varenicline Significantly Enhances Nicotine Vaping Cessation in Youth: Insights from a Landmark Randomized Clinical Trial

By MedXY 08/25/2025

A randomized clinical trial demonstrates that varenicline, combined with behavioral counseling, markedly improves nicotine vaping cessation rates in youth aged 16-25 who vape daily and do not regularly smoke tobacco.

Clinical Updates news Public Health Specialties

Evaluating Dual Use: How E-Cigarettes Influence Real-Time Smoking Reduction in Combustible Cigarette Users

By MedXY 08/25/2025

Dual use of e-cigarettes and combustible cigarettes reduces smoking frequency and increases smoke-free days, as shown in a large U.S. randomized trial with adults who smoke.

Pediatrics Psychiatry Public Health Specialties

Does Increasing Cigarette Use Stabilize Mood? Insights from a 6-Year Real-Time Adolescent Study

By MedXY 08/25/2025

Longitudinal observational data reveal that as adolescents increase cigarette use, their immediate post-smoking mood stabilizes, with boys showing stabilization in background mood as well.

Cardiology Clinical Updates news Public Health Specialties

Decoding 10-Year Cardiovascular Risk in Ethiopia: The Impact of Individual and Community Factors

By MedXY 08/25/2025

A population-based study in Ethiopia reveals 7.3% of adults aged 40-69 face a 10-year cardiovascular disease risk ≥10%, influenced by urban residence, education, physical activity, employment status, and climate factors.

Critical Care news Public Health Respiratory Specialties

Global Shifts in Pulmonary Embolism Mortality: A 2001-2023 WHO Database Analysis

By MedXY 08/25/2025

Analysis of WHO data reveals declining global pulmonary embolism mortality overall, with marked differences by region and income, highlighting urgent needs in lower-middle-income countries.

news Oncology Public Health Specialties

International Trends in Biliary Tract Cancer Mortality from 2000 to 2022: A Comprehensive WHO Database Analysis

By MedXY 08/25/2025

This observational study reveals stable global biliary tract cancer mortality rates over two decades, with a striking rise in intrahepatic cholangiocarcinoma mortality, underscoring the need for targeted screening and management strategies.

Ophthalmology Public Health Specialties

Michigan’s MI-SIGHT Telemedicine Program: Enhancing Glaucoma Screening, Vision Outcomes, and Cost-Effectiveness in Underserved Communities

By MedXY 08/24/2025

The MI-SIGHT telemedicine program significantly improves vision and eye health outcomes by providing glaucoma and eye disease screening with care navigation in community health centers, demonstrating high satisfaction and cost-effectiveness in underserved populations.

Pediatrics Public Health Specialties

Maternal Bivalent Prefusion F RSV Vaccine Significantly Reduces Infant Hospitalisation in UK: Real-World Evidence from a Multicentre Study

By MedXY 08/22/2025

A UK-wide multicentre study shows maternal bivalent RSV prefusion F vaccination reduces infant hospitalisation for RSV-associated ALRI by up to 72%, confirming real-world effectiveness matching clinical trials.

Oncology Public Health Specialties

Socioeconomic Disparities in Intrahepatic Cholangiocarcinoma in Sweden: Incidence, Treatment, and Survival in a Universal Healthcare Context

By MedXY 08/22/2025

A nationwide Swedish study reveals significant socioeconomic disparities in intrahepatic cholangiocarcinoma incidence, treatment access, and survival despite universal healthcare coverage, underscoring persistent health inequities linked to income.

Family Medicine & Nutrition Public Health Specialties

The younger you smoke, the earlier you age

By MedXY 08/22/2025

Early-life tobacco exposure, including in utero and childhood smoking initiation, significantly accelerates biological aging and is partially mediated by inflammation markers, highlighting critical windows for prevention.